Does CRL pay a dividend?

The cached stock data on this page does not show a positive dividend yield for CRL. Dividend status can change, so verify the latest company filings before relying on income assumptions.

What does CRL stock do?

Contract Research Organization (CRO) providing end-to-end drug discovery and development services.

What is CRL stock's price target?

This cached page does not contain a precise model fair value for CRL.

The TradeMates model verdict for CRL is HOLD with an investment score of 58/100. Treat this as a model signal to review, not a personal buy recommendation.

Is CRL a good dividend stock?

CRL is not presented as a dividend idea on this cached TradeMates page because no positive dividend yield is available in the cached data.

CRL (CRL) Stock Analysis

Q: Is CRL stock a good investment?

The cached TradeMates AI model rates CRL as HOLD with an investment score of 58/100. CRL is experiencing a sentiment-driven recovery following a positive Q2 earnings surprise. However, fundamental risks including high net debt (12.8x EBITDA) and aggressive insider selling suggest the rally may be nearing exhaustion. This is algorithmic model output, not personal investment advice.

Verdict: HOLD

Earnings beat and book-to-bill recovery trigger a tactical rally, but extreme valuation premiums and high debt cap the long-term upside.

Investment score: 58/100

CRL is experiencing a sentiment-driven recovery following a positive Q2 earnings surprise. However, fundamental risks including high net debt (12.8x EBITDA) and aggressive insider selling suggest the rally may be nearing exhaustion.

Peers

ILMN
MTD
WST
MEDP
TEM

Peer	P/E	P/B	P/S	EV/EBITDA	ROIC %	Net margin %
ILMN	37.19	10.71	6.78	23.43	—	0.18
MTD	32.34	2260.38	7.04	24.05	—	0.22
WST	44.75	8.34	7.45	29.92	—	0.17
MEDP	33.61	38.14	5.86	26.46	—	0.18
TEM	-33.19	19.19	5.81	-100.77	—	-0.18

View the full interactive analysis